Prognostic value of Biomarkers around Transcatheter Aortic Valve Implantatio

Completed

• Conditions: aortic valve narrowing; aortic valve stenosis; 10046973

• Registration Number: NL-OMON37864
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

transcatheter aortic valve implantation

Exclusion Criteria

No additional exclusion criteria besides exclusion criteria for transcatheter aortic valve implantation are applicable for extra blood samples

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is to document the course of biomarkers around<br /><br>transcatheter aortic valve implantation. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The course of biomarkers will be correlated to short and long term clinical<br /><br>outcomes and change in left ventricular function after transcatheter aortic<br /><br>valve implantation, measured non-invasively with echocardiography and cardiac<br /><br>CT and MRI, </p><br>